Session Type
Meeting
Search Results for Opioid
Abstract Number: 83
Hospital Medicine 2020, Virtual Competition
Background: The US has a heavy burden of deaths from opioid overdoses, and New Mexico is not excepted from this. Treatment options for opioid use disorder (OUD) are buprenorphine/naloxone (“Suboxone”), methadone, naltrexone, counseling, and/or behavioral therapy. Long-acting oral opioids like Suboxone, are the most effective methods for treating opioid withdrawal and OUD. They are often […]
Abstract Number: 87
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Pain remains a major concern for medically hospitalized adults, and pain treatment is a focus of hospital quality reporting and improvement efforts. Pharmacologic treatment during hospitalization for acute pain and cancer pain rest on some evidence, but as many as 1 in 3 adult medical inpatients suffer from chronic pain. Little is known about […]
Abstract Number: 98
SHM Converge 2021
Background: Prior case reports and case-series reports have shown an association between Opioid use disorder and Thrombotic Thrombocytopenic Purpura (TTP). However, clinical data regarding Thrombotic Thrombocytopenic Purpura co-existing with Opioid use disorder are still lacking in the literature. We aim to study patient characteristics, epidemiology, co-morbidities, and clinical outcomes in these patients. Methods: We analyzed […]
Abstract Number: B2
SHM Converge 2022
Background: Patients with limited English proficiency (LEP) experience inferior health outcomes. The end-of-life period represents a particularly vulnerable time for LEP patients who may not receive optimal symptom management due to language barriers and other factors. There is limited data on disparities in provider practices around opioid administration based on patient LEP status, particularly at […]
Abstract Number: G6
SHM Converge 2022
Background: Methylnaltrexone (MNTX) is a peripherally acting µ-opioid receptor antagonist indicated for opioid-induced constipation (OIC). We evaluated whether baseline use of laxatives, including stimulants, osmotic agents, stool softeners, or combinations thereof affects the efficacy and safety of MNTX. Methods: This post hoc analysis included pooled data from 2 multicenter, randomized, double-blind, placebo (PBO)-controlled, institutional review […]
Abstract Number: G8
SHM Converge 2022
Background: With the dramatic increase in the usage of opioids for not only inpatient but also outpatient pain management, a potential increase in opioid-related deaths had led to a national concern regarding opioid usage. The World Health Organization analgesic ladder estimates 90% of the global population will use opioids at least once in their life, […]
Abstract Number: 100
SHM Converge 2023
Background: Opioid use disorder (OUD) is a growing health crisis in the United States (US). Buprenorphine treatment for OUD has been found to improve outcomes and reduce mortality, although disparities in access to treatment and outcomes for OUD exist. Previous studies have shown that those retained in treatment for longer durations are more likely to […]
Abstract Number: 119
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: The volume of opioid prescriptions in the US has increased dramatically over the last two decades, and strong evidence suggests that this has perpetuated opioid misuse, addiction, overdose, and drug-related deaths. We aimed to learn if there are differences in opioid prescribing among generalist physicians, NPs, and PAs to Medicare beneficiaries. Methods: We performed […]
Abstract Number: 138
Hospital Medicine 2020, Virtual Competition
Background: Persons with opioid use disorders (OUD) represent a disproportionately high percentage of hospitalized patients, have greater lengths of stay and readmissions, can incur higher costs, and are at greater risk of drug-related death immediately post-discharge. Further, despite the availability of effective medications for OUD, patients often are not offered treatment during the inpatient encounter. […]
Abstract Number: 147
SHM Converge 2024
Background: As of 2020, a reported 2.7 million people in the United States have opioid use disorder (OUD). Hospitalizations related to opioid use have risen dramatically over the last two decades. Inpatients with substance use disorders are at increased risk of leaving the hospital prior to treatment completion which can further lead to poor health […]